Innovation in histology by biotechnology firms often involves the development of cutting-edge technologies. For instance, digital pathology systems allow for high-resolution scanning and analysis of tissue slides, enhancing accuracy and reproducibility. Additionally, firms are developing advanced immunohistochemistry techniques that enable the detection of specific proteins within tissues, pivotal for understanding disease mechanisms.
